The company has market capitalization of $3.11B. The company stock was upgraded to Outperform from Underperform, wrote analysts at CLSA, in a research note issued to clients on Wednesday August 03, 2016. Analyst had a consensus of $0.78. Sell-side firms, on a consensus basis have a $94.64 price target on the name and a 2.40 recommendation, according to First Call.
Advertisement
The 52 week high of Mead Johnson Nutrition Company’s shares is 94.4 whilst the 52 week low for the company’s shares is 65.53.
As of writing, Mead Johnson Nutrition Company (NYSE:MJN)’s RSI stands at 22.20. During its last trading session, Stock traded with the total exchanged volume of 1.92 million shares. It assesses shares price by the relative expense of the stock. Current price level places the company’s stock about -15.26% from the 52-week high and 23.34% away from the 52-week low. (NYSE:MJN) had its price objective decreased by stock analysts at Citigroup from $106.00 to $103.00 in a note issued to investors on Thursday.
The simple 20 day moving average for Mead Johnson Nutrition Company is -9.20% and the simple 200-day moving average is at -1.44%. It has been assigned a low target price of $46 and a high target price of $60.
Deutsche Bank AG set a $88.00 target price on Mead Johnson Nutrition and gave the company a “hold” rating in a report on Sunday, July 24th.
In Mead Johnson Nutrition CO (NYSE:MJN) latest quarter ended on 30 Jun 2016, company announced earnings of $0.88. Casiano Kimberly A retains 7,110 shares in the stock after this transaction. “4” brokerage firms have rated the company as a “Hold”.
Mead Johnson Nutrition CO closed down -1.75 points or -2.06% at $83.32 with 17,73,221 shares getting traded on Thursday. Current price places the company’s stock -1.39% away from its 200-day simple moving average, -9.08%, away from the 50-day average and also -6.26% away from 20-day average. The company’s revenue was down -8.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.76 EPS. The company had revenue of $941.50 million for the quarter, compared to analysts expectations of $963.64 million.
Advertisement
Mead Johnson Nutrition Company’s ROA is now valued at 12.90% * with a ROI value of 30.60% *. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. This state Mead Johnson Nutrition Company shares price has to travel more than $-16.82 to register a new high of 52-weeks or drop +18.39% to touch a new 52-week low point. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas childrens milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders.
